VL-TP2; HIV-1 viral load (copies/ml) at time point 2; VL-TP3; HIV-1 viral load (copies/ml) at time point 3; N: number of patients; n.d.: not determined; TaqMan v2.0: COBAS Ampliprep/COBAS TaqMan v2.0
The approach described herein is crucial to bring standardization and to ensure the quality of the generated sequences in clinical setting. We provide an easy-to-use single protocol successfully evalu
All vaccinated mice were intranasally (i.n.) challenged with 30 µl 105 TCID50/ml of the CA/04/09 virus 2 weeks after the last immunization. Lung tissue samples were obtained at 2, 4, 6, and 8 days of
BAL = bronchoalveolar lavage. aSome cases were associated with two or more pathogens; two viruses were identified in eight patients and three viruses in two patients.